The DOI matches its Crossref record; 123 of the 123 references it cites were found in a registry or an index.
Challenges in design and characterization of ligand-targeted drug delivery systems
Open accessAbstract
Targeting of therapeutic agents to molecular markers expressed on the surface of cells requiring clinical intervention holds promise to improve specificity of delivery, enhancing therapeutic effects while decreasing potential damage to healthy tissues. Drug targeting to cellular receptors involved in endocytic transport facilitates intracellular delivery, a requirement for a number of therapeutic goals. However, after several decades of experimental design, there is still considerable controversy on the practical outcome of drug targeting strategies. The plethora of factors contributing to the relative efficacy of targeting makes the success of these approaches hardly predictable. Lack of fully specific targets, along with selection of targets with spatial and temporal expression well aligned to interventional requirements, pose difficulties to this process. Selection of adequate sub-molecular target epitopes determines accessibility for anchoring of drug conjugates and bulkier drug carriers, as well as proper signaling for uptake within the cell. Targeting design must adapt to physiological variables of blood flow, disease status, and tissue architecture by accommodating physicochemical parameters such as carrier composition, functionalization, geometry, and avidity. In many cases, opposite features need to meet a balance, e.g., sustained circulation versus efficient targeting, penetration through tissues versus uptake within cells, internalization within endocytic compartment to avoid efflux pumps versus accessibility to molecular targets within the cytosol, etc. Detailed characterization of these complex physiological factors and design parameters, along with a deep understanding of the mechanisms governing the interaction of targeted drugs and carriers with the biological environment, are necessary steps toward achieving efficient drug targeting systems.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Continuous cultures of fused cells secreting antibody of predefined specificity
KÖHLER, G., & MILSTEIN, C. (1975) · Nature · doi:10.1038/256495a0 · Cited by 17,229
Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,781
Regulated portals of entry into the cell
Conner, S. D., & Schmid, S. L. (2003) · Nature · doi:10.1038/nature01451 · Cited by 3,805
Biodegradable nanoparticles for drug and gene delivery to cells and tissue
Panyam, J., & Labhasetwar, V. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00228-4 · Cited by 3,361
The dawning era of polymer therapeutics
Duncan, R. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1088 · Cited by 3,269
Cellular uptake of the tat protein from human immunodeficiency virus
Frankel, A. D., & Pabo, C. O. (1988) · Cell · doi:10.1016/0092-8674(88)90263-2 · Cited by 2,783
Shape effects of filaments versus spherical particles in flow and drug delivery
Geng, Y., Dalhaimer, P., Cai, S., Tsai, R., Tewari, M., Minko, T., & Discher, D. E. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.70 · Cited by 2,565
Dustin, M. L., Rothlein, R., Bhan, A. K., Dinarello, C. A., & Springer, T. A. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.137.1.245 · Cited by 2,450
Role of target geometry in phagocytosis
Champion, J. A., & Mitragotri, S. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600997103 · Cited by 2,074
(2016) · CRC Press eBooks · doi:10.1201/b12801 · Cited by 2,031
Nanomedicine: current status and future prospects
Moghimi, S. M., Hunter, A. C., & Murray, J. C. (2005) · The FASEB Journal · doi:10.1096/fj.04-2747rev · Cited by 2,029
Targeted drug delivery to tumors: Myths, reality and possibility
Bae, Y. H., & Park, K. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.06.001 · Cited by 1,935
Ligand-targeted therapeutics in anticancer therapy
Allen, T. M. (2002) · Nature Reviews Cancer · doi:10.1038/nrc903 · Cited by 1,647
Endosomal escape pathways for delivery of biologicals
Varkouhi, A. K., Scholte, M., Storm, G., & Haisma, H. J. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.11.004 · Cited by 1,561
A human intercellular adhesion molecule (ICAM-1) distinct from LFA-1.
Rothlein, R., Dustin, M. L., Marlin, S. D., & Springer, T. A. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.137.4.1270 · Cited by 1,400
TORCHILIN, V (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.09.009 · Cited by 1,273
Moghimi, S. M., & Szebeni, J. (2003) · Progress in Lipid Research · doi:10.1016/s0163-7827(03)00033-x · Cited by 1,227
Endocytic mechanisms for targeted drug delivery☆
BAREFORD, L., & SWAAN, P. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.06.008 · Cited by 1,033
Intercellular Trafficking and Protein Delivery by a Herpesvirus Structural Protein
Elliott, G., & O'Hare, P. (1997) · Cell · doi:10.1016/s0092-8674(00)81843-7 · Cited by 972
Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis.
Pasqualini, R., Koivunen, E., Kain, R., Lahdenranta, J., Sakamoto, M., Stryhn, A., Ashmun, R., Shapiro, L., Arap, W., & Ruoslahti, E. I. (2000) · PubMed · Cited by 966
Antibody targeted drugs as cancer therapeutics
Schrama, D., Reisfeld, R. A., & Becker, J. C. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1957 · Cited by 768
The origins and evolution of “controlled” drug delivery systems
Hoffman, A. S. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.08.012 · Cited by 738
Subcellular targeting strategies for drug design and delivery
Rajendran, L., Knölker, H.-J., & Simons, K. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd2897 · Cited by 708
Torchilin, V. P. (2000) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(00)00166-4 · Cited by 680
Carman, C. V., & Springer, T. A. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200404129 · Cited by 658
Nonviral gene therapy: promises and challenges
Li, S., & Huang, L. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301110 · Cited by 614
Li, W. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.041 · Cited by 588
Folate-targeted therapeutic and imaging agents for cancer
Low, P. S., & Kularatne, S. A. (2009) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2009.03.022 · Cited by 585
In Vivo Biodistribution of Nanoparticles
Almeida, J. P. M., Chen, A. L., Foster, A., & Drezek, R. (2011) · Nanomedicine · doi:10.2217/nnm.11.79 · Cited by 583
Passive and Active Drug Targeting: Drug Delivery to Tumors as an Example
Torchilin, V. P. (2010) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-00477-3_1 · Cited by 573
Tumor targeting with a selective gelatinase inhibitor
Koivunen, E., Arap, W., Valtanen, H., Rainisalo, A., Medina, O. P., Heikkilä, P., Kantor, C., Gahmberg, C. G., Salo, T., Konttinen, Y. T., et al. (1999) · Nature Biotechnology · doi:10.1038/11703 · Cited by 567
Muro, S., Garnacho, C., Champion, J. A., Leferovich, J., Gajewski, C., Schuchman, E. H., Mitragotri, S., & Muzykantov, V. R. (2008) · Molecular Therapy · doi:10.1038/mt.2008.127 · Cited by 564
Self-citationReceptor‐mediated transcytosis of transferrin across the blood‐brain barrier
Fishman, J. B., Rubin, J. B., Handrahan, J. V., Connor, J. R., & Fine, R. E. (1987) · Journal of Neuroscience Research · doi:10.1002/jnr.490180206 · Cited by 544
Lamaze, C., Dujeancourt, A., Baba, T., Lo, C. G., Benmerah, A., & Dautry-Varsat, A. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00212-x · Cited by 525
Introduction to current and future protein therapeutics: A protein engineering perspective
Carter, P. J. (2011) · Experimental Cell Research · doi:10.1016/j.yexcr.2011.02.013 · Cited by 467
El-Sayed, A., Futaki, S., & Harashima, H. (2009) · The AAPS Journal · doi:10.1208/s12248-008-9071-2 · Cited by 465
Folate-targeted therapies for cancer
Xia, W., & Low, P. S. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100509v · Cited by 448
Pardridge, W. M. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9324-2 · Cited by 447
Lectin-mediated drug targeting: history and applications
Bies, C., Lehr, C.-M., & Woodley, J. F. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.030 · Cited by 414
Millán, J., Hewlett, L., Glyn, M., Toomre, D., Clark, P., & Ridley, A. J. (2006) · Nature Cell Biology · doi:10.1038/ncb1356 · Cited by 414
Frey, A., Giannasca, K. T., Weltzin, R., Giannasca, P. J., Reggio, H., Lencer, W. I., & Neutra, M. R. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.3.1045 · Cited by 401
Petersen, J., Dandri, M., Mier, W., Lütgehetmann, M., Volz, T., von Weizsäcker, F., Haberkorn, U., Fischer, L., Pollok, J.-M., Erbes, B., et al. (2008) · Nature Biotechnology · doi:10.1038/nbt1389 · Cited by 397
Tiruppathi, C., Song, W., Bergenfeldt, M., Sass, P., & Malik, A. B. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.41.25968 · Cited by 391
Polycation gene delivery systems: escape from endosomes to cytosol
Cho, Y. W., Kim, J.-D., & Park, K. (2003) · Journal of Pharmacy and Pharmacology · doi:10.1211/002235703765951311 · Cited by 370
Muller, W. A., Ratti, C. M., McDonnell, S. L., & Cohn, Z. A. (1989) · The Journal of experimental medicine · doi:10.1084/jem.170.2.399 · Cited by 358
Seo, J.-W., & Lee, K.-J. (2004) · BMB Reports · doi:10.5483/bmbrep.2004.37.1.035 · Cited by 358
Brekken, R. A., Overholser, J. P., Stastny, V., Waltenberger, J. L., Minna, J. D., & Thorpe, P. E. (2000) · PubMed · Cited by 331
Human MUC1 carcinoma-associated protein confers resistance to genotoxic anticancer agents
Ren, J., Agata, N., Chen, D., Li, Y., Yu, W.-H., Huang, L., Raina, D., Chen, W., Kharbanda, S., & Kufe, D. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00020-0 · Cited by 325
Covic, L., Gresser, A. L., Talavera, J., Swift, S., & Kuliopulos, A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.022460899 · Cited by 314
A novel endocytic pathway induced by clustering endothelial ICAM-1 or PECAM-1
Muro, S., Wiewrodt, R., Thomas, A., Koniaris, L., Albelda, S. M., Muzykantov, V. R., & Koval, M. (2003) · Journal of Cell Science · doi:10.1242/jcs.00367 · Cited by 302
Self-citationOh, P., Borgström, P., Witkiewicz, H., Li, Y., Borgström, B. J., Chrastina, A., Iwata, K., Zinn, K. R., Baldwin, R., Testa, J. E., et al. (2007) · Nature Biotechnology · doi:10.1038/nbt1292 · Cited by 300
Identification of a peptide blocking vascular endothelial growth factor (VEGF)-mediated angiogenesis
Binetruy-Tournaire, R. (2000) · The EMBO Journal · doi:10.1093/emboj/19.7.1525 · Cited by 295
Enzyme replacement and enhancement therapies: lessons from lysosomal disorders
Desnick, R. J., & Schuchman, E. H. (2002) · Nature Reviews Genetics · doi:10.1038/nrg963 · Cited by 268
Iron absorption and transport?An update
Conrad, M. E., & Umbreit, J. N. (2000) · American Journal of Hematology · doi:10.1002/1096-8652(200008)64:4<287::aid-ajh9>3.0.co;2-l · Cited by 253
An Address System in the Vasculature of Normal Tissues and Tumors
Ruoslahti, E., & Rajotte, D. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.813 · Cited by 239
Affinity and Avidity in Antibody-Based Tumor Targeting
Rudnick, S. I., & Adams, G. P. (2009) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2009.0627 · Cited by 237
Drug targeting and tumor heterogeneity
Bae, Y. H. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.09.074 · Cited by 233
Zheng, G., Chen, J., Li, H., & Glickson, J. D. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508677102 · Cited by 226
18F-4V for PET–CT Imaging of VCAM-1 Expression in Atherosclerosis
Nahrendorf, M., Keliher, E., Panizzi, P., Zhang, H., Hembrador, S., Figueiredo, J.-L., Aikawa, E., Kelly, K., Libby, P., & Weissleder, R. (2009) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2009.04.016 · Cited by 224
High avidity scFv multimers; diabodies and triabodies
Hudson, P. J., & Kortt, A. A. (1999) · Journal of Immunological Methods · doi:10.1016/s0022-1759(99)00157-x · Cited by 219
Engineering design and molecular dynamics of mucoadhesive drug delivery systems as targeting agents
Serra, L., Doménech, J., & Peppas, N. A. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.09.022 · Cited by 217
Targeted Drugs and Nanomedicine: Present and Future
Debbage, P. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209787002870 · Cited by 213
Cell-penetrating peptides for drug delivery across membrane barriers
Foged, C., & Nielsen, H. M. (2008) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.5.1.105 · Cited by 205
Molecular and Cellular Mechanisms of Ectodomain Shedding
Hayashida, K., Bartlett, A. H., Chen, Y., & Park, P. W. (2010) · The Anatomical Record · doi:10.1002/ar.20757 · Cited by 197
Muro, S., Dziubla, T., Qiu, W., Leferovich, J., Cui, X., Berk, E., & Muzykantov, V. R. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.098970 · Cited by 192
Self-citationOvercoming in vivo barriers to targeted nanodelivery
Chrastina, A., Massey, K. A., & Schnitzer, J. E. (2011) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.143 · Cited by 189
Peptide Phage Display as a Tool for Drug Discovery: Targeting Membrane Receptors
Molek, P., Strukelj, B., & Bratkovic, T. (2011) · Molecules · doi:10.3390/molecules16010857 · Cited by 187
Kirkpatrick, P. N., Graham, J., & Muhsin, M. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1445 · Cited by 183
Ligand-Receptor-Mediated Drug Delivery: An Emerging Paradigm in Cellular Drug Targeting
Vyas, S. P., Singh, A., & Sihorkar, V. (2001) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v18.i1.10 · Cited by 180
IGF-1 Receptor Inhibitors in Clinical Trials—Early Lessons
Weroha, S. J., & Haluska, P. (2008) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-008-9104-6 · Cited by 178
Schnitzer, J. E. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00141-7 · Cited by 176
Noonberg, S. B., & Benz, C. C. (2000) · Drugs · doi:10.2165/00003495-200059040-00003 · Cited by 173
Immunoliposomes for the targeted delivery of antitumor drugs
Mastrobattista, E., Koning, G. A., & Storm, G. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(99)00043-5 · Cited by 172
Kumar, C. C., Malkowski, M., Yin, Z., Tanghetti, E., Yaremko, B., Nechuta, T. L., Varner, J. A., Liu, M., Smith, E. M., Neustadt, B. R., et al. (2001) · PubMed · Cited by 172
Structure and function of endothelial caveolae
Stan, R. (2002) · Microscopy Research and Technique · doi:10.1002/jemt.10089 · Cited by 167
Fonsatti, E., Nicolay, H. J. M., Altomonte, M., Covre, A., & Maio, M. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvp332 · Cited by 165
Size of IgG-Opsonized Particles Determines Macrophage Response during Internalization
Koval, M., Preiter, K., Adles, C., Stahl, P. D., & Steinberg, T. H. (1998) · Experimental Cell Research · doi:10.1006/excr.1998.4110 · Cited by 163
Andreadis, A., Gallego, M. E., & Nadal‐Ginard, B. (1987) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.03.110187.001231 · Cited by 160
Matrix metalloproteases: Underutilized targets for drug delivery
Vartak, D. G., & Gemeinhart, R. A. (2007) · Journal of drug targeting · doi:10.1080/10611860600968967 · Cited by 159
Targeted Delivery Systems for Oligonucleotide Therapeutics
Yu, B., Zhao, X., Lee, L. J., & Lee, R. J. (2009) · The AAPS Journal · doi:10.1208/s12248-009-9096-1 · Cited by 158
Potential role of the low-density lipoprotein receptor family as mediators of cellular drug uptake
Chung, N. S., & Wasan, K. M. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.12.003 · Cited by 158
Lipid Vesicle Size Determines the Th1 or Th2 Response to Entrapped Antigen
Brewer, J. M., Tetley, L., Richmond, J. A., et al. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.8.4000 · Cited by 154
Hatakeyama, H., Akita, H., Maruyama, K., Suhara, T., & Harashima, H. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.05.025 · Cited by 147
Boado, R. J., Zhang, Y., Zhang, Y., Xia, C., Wang, Y., & Pardridge, W. M. (2007) · Biotechnology and Bioengineering · doi:10.1002/bit.21602 · Cited by 142
Muro, S., Gajewski, C., Koval, M. H., & Muzykantov, V. R. (2004) · Blood · doi:10.1182/blood-2004-05-1714 · Cited by 140
Self-citationTransport Across the Endothelium: Regulation of Endothelial Permeability
Minshall, R. D., & Malik, A. B. (2006) · Springer eBooks · doi:10.1007/3-540-32967-6_4 · Cited by 139
Plasmalemmal vesicles represent the large pore system of continuous microvascular endothelium
Predescu, D. N., & Palade, G. E. (1993) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1993.265.2.h725 · Cited by 135
Cell Adhesion Molecules for Targeted Drug Delivery
Dunehoo, A. L., Anderson, M. E., Majumdar, S., Kobayashi, N., Berkland, C. J., & Siahaan, T. J. (2006) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20676 · Cited by 129
Endothelial transport of macromolecules: transcytosis and endocytosis. A look from cell biology.
Simionescu, M., & Simionescu, N. (1991) · PubMed · Cited by 128
Acidification and Ion Permeabilities of Highly Purified Rat Liver Endosomes
Fuchs, R., Mâle, P., & Mellman, I. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)94164-5 · Cited by 124
Protein toxins: intracellular trafficking for targeted therapy
Johannes, L., & Decaudin, D. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302557 · Cited by 123
Endothelial Endocytic Pathways: Gates for Vascular Drug Delivery
Muro, S., Koval, M. H., & Muzykantov, V. R. (2004) · Current Vascular Pharmacology · doi:10.2174/1570161043385736 · Cited by 122
Self-citationSchröder, T., Niemeier, N., Afonin, S., Ulrich, A. S., Krug, H. F., & Bräse, S. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm070603m · Cited by 117
Endothelial Targeting of Antibody-Decorated Polymeric Filomicelles
Shuvaev, V. V., Ilies, M. A., Simone, E. A., Zaitsev, S. V., Kim, Y., Cai, S., Mahmud, A., Dziubla, T. D., Muro, S., Discher, D. E., et al. (2011) · ACS Nano · doi:10.1021/nn2015453 · Cited by 117
Self-citationCirstoiu-Hapca, A., Bossy-Nobs, L., Buchegger, F., Gurny, R., & Delié, F. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.12.002 · Cited by 116
Membrane-Anchored Peptide Inhibits Human Immunodeficiency Virus Entry
Hildinger, M., Dittmar, M. T., Schult-Dietrich, P., Fehse, B., Schnierle, B. S., Thaler, S., Stiegler, G. M., Welker, R., & von Laer, D. (2001) · Journal of Virology · doi:10.1128/jvi.75.6.3038-3042.2001 · Cited by 110
ICAM-directed vascular immunotargeting of antithrombotic agents to the endothelial luminal surface
Murciano, J.-C., Muro, S., Koniaris, L. S., Christofidou‐Solomidou, M., Harshaw, D. W., Albelda, S. Μ., Granger, D. N., Cines, D. B., & Muzykantov, V. R. (2003) · Blood · doi:10.1182/blood-2002-09-2853 · Cited by 108
Self-citationED-B fibronectin as a target for antibody-based cancer treatments
Menrad, A., & Menssen, H. D. (2005) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.9.3.491 · Cited by 102
Targeting of Antioxidant and Anti-Thrombotic Drugs to Endothelial Cell Adhesion Molecules
Muro, S., & Muzykantov, V. R. (2005) · Current Pharmaceutical Design · doi:10.2174/1381612054367274 · Cited by 101
Self-citation‘Smart’ delivery systems for biomolecular therapeutics
Stayton, P. S., El‐Sayed, M., Murthy, N., et al. (2005) · Orthodontics and Craniofacial Research · doi:10.1111/j.1601-6343.2005.00336.x · Cited by 100
Issues related to targeted delivery of proteins and peptides
Lu, Y. J., Yang, J. J. J., & Sega, E. I. (2006) · The AAPS Journal · doi:10.1208/aapsj080355 · Cited by 99
LeBowitz, J. H., Grubb, J. H., Maga, J. A., Schmiel, D. H., Vogler, C. A., & Sly, W. S. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308728100 · Cited by 99
Evaluation of Multivalent, Functional Polymeric Nanoparticles for Imaging Applications
Shokeen, M., Pressly, E. D., Hagooly, A., Zheleznyak, A., Ramos, N. N., Fiamengo, A. L., Welch, M. J., Hawker, C. J., & Anderson, C. J. (2011) · ACS Nano · doi:10.1021/nn102278w · Cited by 94
Jones, A. T. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.10.046 · Cited by 84
Biomedical aspects of targeted delivery of drugs to pulmonary endothelium
Muzykantov, V. R. (2005) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2.5.909 · Cited by 83
Endogenous carriers and ligands in non-immunogenic site-specific drug delivery
Vyas, S. P., & Sihorkar, V. (2000) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00067-3 · Cited by 82
The effect of CD47 modified polymer surfaces on inflammatory cell attachment and activation
Stachelek, S. J., Finley, M. J., Alferiev, I. S., Wang, F., Tsai, R. K., Eckells, E. C., Tomczyk, N. A., Connolly, J. M., Discher, D. E., Eckmann, D. M., et al. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.02.053 · Cited by 82
Biomedical Aspects of Drug Targeting
(2002) · Springer eBooks · doi:10.1007/978-1-4757-4627-3 · Cited by 80
Smart polymeric carriers for enhanced intracellular delivery of therapeutic macromolecules
ElSayed, M. E. H., Hoffman, A. S., & Stayton, P. S. (2005) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.5.1.23 · Cited by 79
Integrated??Pharmacokinetics??and Pharmacodynamics in??Drug??Development
Dingemanse, J., & Appel‐Dingemanse, S. (2007) · Clinical Pharmacokinetics · doi:10.2165/00003088-200746090-00001 · Cited by 75
Everts, M., Koning, G. A., Kok, R. J., et al. (2003) · Pharmaceutical Research · doi:10.1023/a:1022298725165 · Cited by 74
Calderon, A. J., Bhowmick, T. K., Leferovich, J. M., Burman, B., Pichette, B., Muzykantov, V. R., Eckmann, D. M., & Muro, S. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.10.025 · Cited by 74
Self-citationPeptide‐mediated cancer targeting of nanoconjugates
Raha, S., Paunesku, T., & Woloschak, G. E. (2010) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.121 · Cited by 70
Ghaffarian, R., Bhowmick, T. K., & Muro, S. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.06.007 · Cited by 64
Self-citationExploitation of major histocompatibility complex class I molecules and caveolae by simian virus 40
Parton, R. G., & Lindsay, M. R. (1999) · Immunological Reviews · doi:10.1111/j.1600-065x.1999.tb01280.x · Cited by 64
Targeting large molecules to mitochondria
Muratovska, A., Lightowlers, R. N., Taylor, R. W., Wilce, M. C. J., & Murphy, M. P. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00134-x · Cited by 63
Brain Drug Development and Brain Drug Targeting
Pardridge, W. M. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9387-0 · Cited by 59
Prince, W. S., McCormick, L. M., Wendt, D. J., Fitzpatrick, P., Schwartz, K. L., Aguilera, A. I., Koppaka, V., Christianson, T., Vellard, M. C., Pavloff, N., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402630200 · Cited by 49
Cooke, J. P. (2008) · Circulation · doi:10.1161/circulationaha.107.740308 · Cited by 34
Endocytosis pathways in endothelium: how many?
Stan, R. V. (2006) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00533.2005 · Cited by 27
Yoon, D. J., Liu, C. T., Quinlan, D. S., Nafisi, P. M., & Kamei, D. T. (2011) · Annals of Biomedical Engineering · doi:10.1007/s10439-011-0280-y · Cited by 25
Mastrobattista, E., Hennink, W. E., & Schiffelers, R. M. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9349-6 · Cited by 24
Targeting and Imaging Signature Caveolar Molecules in Lungs
Massey, K. A., & Schnitzer, J. E. (2009) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200903-011aw · Cited by 15
Cited by
Nano based drug delivery systems: recent developments and future prospects
Patra, J. K., Das, G., Fraceto, L. F., Campos, E. V. R., Rodriguez-Torres, M. D. P., Acosta-Torres, L. S., Diaz-Torres, L. A., Grillo, R., Swamy, M. K., Sharma, S., et al. (2018) · Journal of Nanobiotechnology · doi:10.1186/s12951-018-0392-8 · Cited by 6,684
Targeting Strategies for Tissue-Specific Drug Delivery
Zhao, Z., Ukidve, A., Kim, J., & Mitragotri, S. (2020) · Cell · doi:10.1016/j.cell.2020.02.001 · Cited by 1,099
Asialoglycoprotein receptor mediated hepatocyte targeting — Strategies and applications
D'Souza, A. A., & Devarajan, P. V. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.02.022 · Cited by 621
Srinivasarao, M., & Low, P. S. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00013 · Cited by 605
Advanced application of stimuli-responsive drug delivery system for inflammatory arthritis treatment
Zhang, M., Hu, W., Cai, C., Wu, Y., Li, J., & Dong, S. (2022) · Materials Today Bio · doi:10.1016/j.mtbio.2022.100223 · Cited by 394
Metadata
- Authors
- Muro, S.
- Venue
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Published
- 2012-12
- Volume
- 164
- Issue
- 2
- Pages
- 125-137
- ISSN
- 0168-3659 (ISSN-L)
- OpenAlex
- W2001921621
- Cited by
- 307
- References
- 123
- FWCI
- 8.78
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.